Purchase Order 75F40120P00147
Award Date 4/13/20
Potential Completion Date 5/21/25
Potential Value $371K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $229,200.00 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Unchained Labs, LLC, doing business as Optim, a for-profit biotechnology manufacturer. The contract, which has a set-aside for small businesses, is for the delivery of the "FFPHUNK PROTEIN PLATFORM" to support the FDA's "HUNK PROTEIN STABILITY PLATFORM" program. Unchained Labs specializes in advanced scientific instrumentation, equipment, and services for government...
- The Department of Health and Human Services Food and Drug Administration awarded a definitive contract valued at $814,426.75 to Unchained Labs, LLC doing business as Optim. The contract is for the delivery of an Automated Biologic Formulation Analyzer over a three-year period of performance ending March 2023. The place of performance is Silver Spring, Maryland. This firm fixed price contract has a total small business set aside designation. Optim will provide the FDA with the requested...
- The U.S. Food and Drug Administration awarded a sole-source purchase order to Life Technologies Corporation for the procurement of a King Fisher Apex96 deep well instrument for DNA lysate preparation. The contract, valued at $66,736.94 on a firm fixed-price basis, was awarded June 25, 2021, with an ultimate completion date of August 29, 2022. The place of performance is Grand Island, New York. This award reflects the FDA's need for specialized genetic analysis instrumentation to support its...
- This federal contract award from the Food and Drug Administration (FDA) was granted to Unchained Labs, LLC, doing business as Optim, to provide a Fluorescence Protein Thermal Stability Measuring Instrument (Unit). The $151,375.00 firm fixed-price purchase order did not have a set-aside designation. Unchained Labs is a biotechnology research company that specializes in advanced scientific instrumentation, equipment, and services for government research programs, particularly supporting efforts in...
- The U.S. Food and Drug Administration (FDA) awarded a firm fixed-price purchase order contract to Unchained Labs, LLC (doing business as Optim), a for-profit biotechnology research company based in Pleasanton, California. The $158,060.00 contract is for the purchase of a Protein Chemical Stability Analyzer with accessories, training, and four optional years of service agreement. This sole-source contract was not set aside. Unchained Labs, which specializes in advanced scientific...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of one Thermo Fisher Scientific KingFisher Flex Purification System, with a total ceiling value of $65,787.78 and an ultimate completion date of December 17, 2024. The contract was awarded on September 23, 2021 under an unrestricted full and open competition...
- The Department of Health and Human Services' Food and Drug Administration awarded a $749,396.58 firm fixed price purchase order to Pacific Biosciences of California, Inc. to deliver a Versatile Sequencing II System. The sequencing system must be capable of producing long reads between 8,000 to over 20,000 bases, running a minimum of eight multiplexed samples simultaneously, and accommodating a cell confinement structure with 100,000 to 150,000 zero-mode waveguide holes, as specified in the...
- Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., was awarded a $82,231.05 firm fixed-price purchase order by the Food and Drug Administration on August 15, 2022, for an Automated Express Nucleic Acid Extraction System (Part # 4467754). The contract was awarded without set-aside designation and has an ultimate completion date of October 14, 2027. The system will be delivered to the FDA's facility in Grand Island, New York. This award supports the FDA's regulatory...
- The Department of Health and Human Services Food and Drug Administration awarded a $463,101.05 firm fixed price delivery order to Fisher Scientific Company L.L.C. for DNA Analyzer 3730XL-48/96 instruments. The period of performance extends through March 10, 2027 with no set-aside designation. Fisher Scientific will provide the analyzers under its Multiple Award Schedule contract with the General Services Administration. As a leading supplier of laboratory equipment and materials, Fisher...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Unchained Labs, LLC, doing business as Optim, for the delivery of the HUNK protein stability predictor software. The contract has a ceiling value of $222,160.00 and was awarded on August 31, 2016, with a completion date of August 30, 2021. The contract does not have a set-aside designation. Unchained Labs, LLC is a for-profit biotechnology research company that specializes in advanced scientific...